Trials / Completed
CompletedNCT03163550
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Achaogen, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This Phase 1 clinical study is a double-blind, randomized, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics (PK), food effect, and drug interaction potential of ACHN-383 and ACHN-789 co-administered orally as separate capsules in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACHN-383 | Oral dose |
| DRUG | ACHN-789 | Oral dose |
| DRUG | Placebo | Oral dose |
Timeline
- Start date
- 2017-05-17
- Primary completion
- 2017-10-15
- Completion
- 2017-10-15
- First posted
- 2017-05-23
- Last updated
- 2017-12-02
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT03163550. Inclusion in this directory is not an endorsement.